BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34620648)

  • 1. Organizational Characteristics Associated with High Performance in Medicare's Comprehensive End-Stage Renal Disease Care Initiative.
    Drewry KM; Trivedi AN; Wilk AS
    Clin J Am Soc Nephrol; 2021 Oct; 16(10):1522-1530. PubMed ID: 34620648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the Comprehensive End-Stage Renal Disease Care Model With Medicare Payments and Quality of Care for Beneficiaries With End-Stage Renal Disease.
    Marrufo G; Colligan EM; Negrusa B; Ullman D; Messana J; Shah A; Duvall T; Hirth RA
    JAMA Intern Med; 2020 Jun; 180(6):852-860. PubMed ID: 32227133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing mandated health care reforms: the Affordable Care Act, accountable care organizations, and the Medicare ESRD program.
    Watnick S; Weiner DE; Shaffer R; Inrig J; Moe S; Mehrotra R;
    Clin J Am Soc Nephrol; 2012 Sep; 7(9):1535-43. PubMed ID: 22626961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of Markets and Patients Served by ESRD Seamless Care Organizations.
    Hirth RA; Messana JM; Negrusa B; Melin CQ; Li Y; Colligan EM; Marrufo GM
    Med Care Res Rev; 2021 Jun; 78(3):273-280. PubMed ID: 31319737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accountable Care Organizations and Spending for Patients Undergoing Long-Term Dialysis.
    Bakre S; Hollingsworth JM; Yan PL; Lawton EJ; Hirth RA; Shahinian VB
    Clin J Am Soc Nephrol; 2020 Dec; 15(12):1777-1784. PubMed ID: 33234541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESRD special needs plans: a proof of concept for integrated care.
    Krishnan M; Franco E; McMurray S; Petra E; Nissenson AR
    Nephrol News Issues; 2014 Nov; 28(12):30, 32, 34-6. PubMed ID: 26012119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accountable care organizations and ESRD: the time has come.
    Nissenson AR; Maddux FW; Velez RL; Mayne TJ; Parks J
    Am J Kidney Dis; 2012 May; 59(5):724-33. PubMed ID: 22459132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward population management in an integrated care model.
    Maddux FW; McMurray S; Nissenson AR
    Clin J Am Soc Nephrol; 2013 Apr; 8(4):694-700. PubMed ID: 23539229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicare's Specialty-Oriented Accountable Care Organization: First-Year Results For People With End-Stage Renal Disease.
    Ullman DF; Boyer GJ; Negrusa B; Hirth RA; Wiens J; Marrufo G
    Health Aff (Millwood); 2022 Jun; 41(6):893-900. PubMed ID: 35666977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Early Cannulation Grafts on Quality and Cost of Care for Patients With End-Stage Renal Disease.
    Desai SS
    Ann Vasc Surg; 2019 Oct; 60():203-210. PubMed ID: 31200049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare's New Prospective Payment System on Facility Provision of Peritoneal Dialysis.
    Wang V; Coffman CJ; Sanders LL; Lee SD; Hirth RA; Maciejewski ML
    Clin J Am Soc Nephrol; 2018 Dec; 13(12):1833-1841. PubMed ID: 30455323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Market Consolidation and Mortality in Patients Initiating Hemodialysis.
    Erickson KF; Winkelmayer WC; Ho V; Bhattacharya J; Chertow GM
    Value Health; 2019 Jan; 22(1):69-76. PubMed ID: 30661636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiologist Participation in Accountable Care Organizations and Changes in Spending and Quality for Medicare Patients With Cardiovascular Disease.
    Sukul D; Ryan AM; Yan P; Markovitz A; Nallamothu BK; Lewis VA; Hollingsworth JM
    Circ Cardiovasc Qual Outcomes; 2019 Sep; 12(9):e005438. PubMed ID: 31522529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Financial implications to Medicare from changing the dialysis modality mix under the bundled prospective payment system.
    Liu FX; Walton SM; Leipold R; Isbell D; Golper TA
    Perit Dial Int; 2014; 34(7):749-57. PubMed ID: 25292402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-Reported Experiences of Dialysis Care Within a National Pay-for-Performance System.
    Brady BM; Zhao B; Niu J; Winkelmayer WC; Milstein A; Chertow GM; Erickson KF
    JAMA Intern Med; 2018 Oct; 178(10):1358-1367. PubMed ID: 30208398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-Year Outcomes of Early Cannulation Arteriovenous Grafts for End-Stage Renal Disease.
    Desai SS
    Ann Vasc Surg; 2019 Aug; 59():158-166. PubMed ID: 31009720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does One Size Fit All With the Effects of Payment Reform? Dialysis Facility Payer Mix and Anemia Management Under the Expanded Medicare Prospective Payment System.
    Mukhopadhyay P; Pearson J; Cogan C; Gaber C; Gillespie BW; Turenne M
    Med Care; 2019 Aug; 57(8):584-591. PubMed ID: 31295188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional cost and experience, not size or hospital inclusion, helps predict ACO success.
    Schulz J; DeCamp M; Berkowitz SA
    Medicine (Baltimore); 2017 Jun; 96(24):e7209. PubMed ID: 28614267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considering an integrated nephrology care delivery model: six principles for quality.
    Hamm LL; Hostetter TH; Shaffer RN;
    Clin J Am Soc Nephrol; 2013 Apr; 8(4):682-6. PubMed ID: 23184568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in health care spending and quality for Medicare beneficiaries associated with a commercial ACO contract.
    McWilliams JM; Landon BE; Chernew ME
    JAMA; 2013 Aug; 310(8):829-36. PubMed ID: 23982369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.